Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jinhai International Group Holdings Limited ( (HK:2225) ) just unveiled an announcement.
Jinhai Medical Technology Limited has issued a profit warning, anticipating a significant increase in net loss for the first half of 2025, compared to the same period in 2024. The expected loss of approximately S$10.8 million is primarily due to a decrease in gross profit, attributed to reduced revenue from its core business operations. This announcement may impact stakeholders’ perception and requires cautious consideration by investors.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on minimally invasive surgery solutions, medical products, related services, and dormitory services.
Average Trading Volume: 9,029,958
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.65B
For detailed information about 2225 stock, go to TipRanks’ Stock Analysis page.